ARS Pharmaceuticals, Inc. (SPRY)
10.06
+0.13
(+1.31%)
USD |
NASDAQ |
Dec 10, 11:46
ARS Pharmaceuticals Profit Margin (Quarterly): -157.4% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Amgen, Inc. | 33.55% |
| Lipocine, Inc. | -2.78K% |
| KalVista Pharmaceuticals, Inc. | -361.4% |
| Vivos Therapeutics, Inc. | -79.61% |
| MBX Biosciences, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -38.98% |
| Return on Assets | -25.29% |
| Return on Invested Capital | -35.53% |
| Gross Profit Margin (Quarterly) | 74.80% |
| Operating Margin (Quarterly) | -163.7% |
| Return on Net Operating Assets | -208.7% |